A. Ferbert

Publications206
h-index35
Citations5,398
Highly Influential Citations177
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • W. Hacke
  • 1,064 Publications, 67,511 Citations
  • C. Klein
  • 421 Publications, 14,572 Citations
  • S. Züchner
  • 235 Publications, 11,777 Citations
  • W. Kress
  • 214 Publications, 6,362 Citations
  • Publications
  • Influence
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
An open angiography‐based, dose rate escalation study on the effect of intravenous infusion of recombinant tissue plasminogen activator(rt‐PA) on cerebral arterial recanalization in patients with… Expand
  • 917
  • 20
Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.
In this retrospective analysis we report our treatment experience in 65 consecutive patients with clinical signs of severe brainstem ischemia with angiographically demonstrated thrombotic… Expand
  • 753
  • 19
  • PDF
The posterior reversible encephalopathy syndrome: what's certain, what's new?
The posterior reversible encephalopathy syndrome is an increasingly recognised disorder. Most patients have several symptoms; seizures are the most frequent, often multiple or status epilepticus. A… Expand
  • 188
  • 15
Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscular disorder with a wide clinical variability. Contractions of the D4Z4 macrosatellite repeat on chromosome 4q35 are the… Expand
  • 70
  • 12
Posterior reversible encephalopathy syndrome: long-term follow-up
  • C. Roth, A. Ferbert
  • Medicine
  • Journal of Neurology, Neurosurgery & Psychiatry
  • 1 December 2009
Background Posterior reversible encephalopathy syndrome (PRES) has been known for more than 10 years. The long-term prognosis of this condition remains unknown. Patients and methods In 2006, the… Expand
  • 148
  • 10
Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene
A study was undertaken to identify the gene underlying DYT4 dystonia, a dominantly inherited form of spasmodic dysphonia combined with other focal or generalized dystonia and a characteristic facies… Expand
  • 124
  • 7
  • PDF
Screening of ARHSP‐TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion
Autosomal recessive spastic paraplegia with thinning of corpus callosum (ARHSP‐TCC) is a complex form of HSP initially described in Japan but subsequently reported to have a worldwide distribution… Expand
  • 61
  • 7
  • PDF
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
The possibility that intra-arterial local infusion of fibrinolytic agents may achieve recanalization of previously occluded carotid territory arteries in acute stroke was tested in a prospective… Expand
  • 371
  • 5
  • PDF
Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy
OBJECTIVES To investigate the effects of injection of botulinum toxin type A (BTX A) into the orbicularis oculi muscle and lacrimal gland in patients with aberrant regeneration after facial palsy… Expand
  • 118
  • 5
  • PDF
Does age influence early recovery from ischemic stroke?
Abstract. Age is the most important risk factor for developing a stroke. In addition, age may also influence stroke recovery. To allow structured discharge planning, it may be important to consider… Expand
  • 84
  • 4